Liquid Biopsy Market Is Estimated To Witness High Growth Owing To Advancements In Diagnostic Technologies & Increasing Prevalence Of Cancer

The Liquid Biopsy market is estimated to be valued at Us$ 13,220.0 Mn or Bn in 2022 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.